A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition.
about
Purinergic signalling and cancerThe PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritisThe anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis.Molecular mechanisms of A3 adenosine receptor-induced G1 cell cycle arrest and apoptosis in androgen-dependent and independent prostate cancer cell lines: involvement of intrinsic pathway.Growth and metastasis of B16-F10 melanoma cells is not critically dependent on host CD73 expression in mice.Human breast cancer cell line MDA-MB-231 expresses endogenous A2B adenosine receptors mediating a Ca2+ signal.Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression.Pharmacological and therapeutic effects of A3 adenosine receptor agonistsCF102 an A3 adenosine receptor agonist mediates anti-tumor and anti-inflammatory effects in the liver.Tiamulin inhibits breast cancer growth and pulmonary metastasis by decreasing the activity of CD73Modulation of G protein-coupled adenosine receptors by strategically functionalized agonists and antagonists immobilized on gold nanoparticles.Identification of A3 adenosine receptor agonists as novel non-narcotic analgesics.Internalization and desensitization of adenosine receptors.The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-kappaB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis ratsSynthesis and characterization of [76Br]-labeled high-affinity A3 adenosine receptor ligands for positron emission tomography.Adenosine A(3) receptor suppresses prostate cancer metastasis by inhibiting NADPH oxidase activity.Adenosine receptors and cancer.Adenosine receptors: expression, function and regulation.The A3 adenosine receptor as multifaceted therapeutic target: pharmacology, medicinal chemistry, and in silico approaches.Therapeutic potential of A2 and A3 adenosine receptor: a review of novel patented ligands.Immunoregulatory activity of adenosine and its role in human cancer progression.Determination and validation of LJ-2698, a potent human A3 adenosine receptor antagonist, in rat plasma by liquid chromatography-tandem mass spectrometry and its application in pharmacokinetic study.Expression of adenosine receptor subclasses in malignant and adjacent normal human prostate tissues.Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer.A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy.A3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cells.CF101, an agonist to the A3 adenosine receptor, enhances the chemotherapeutic effect of 5-fluorouracil in a colon carcinoma murine model.Polypharmacology of N6-(3-Iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA) and Related A3 Adenosine Receptor Ligands: Peroxisome Proliferator Activated Receptor (PPAR) γ Partial Agonist and PPARδ Antagonist Activity Suggests Their Antidiabetic PoThe Hypoxia-Adenosine Link during Intestinal Inflammation.Radioligand binding and functional responses of ligands for human recombinant adenosine A(3) receptors.Discovery of benzothiazolylquinoline conjugates as novel human A3 receptor antagonists: biological evaluations and molecular docking studies.Mitochondrial and caspase pathways are involved in the induction of apoptosis by IB-MECA in ovarian cancer cell lines.Enhancing pigmentation via activation of A3 adenosine receptors in B16 melanoma cells and in human skin explants.Navigating in chromone chemical space: discovery of novel and distinct A3 adenosine receptor ligandsThe A2B adenosine receptor in MDA-MB-231 breast cancer cells diminishes ERK1/2 phosphorylation by activation of MAPK-phosphatase-1
P2860
Q24618782-FAFA3DAE-C913-4DB6-83E1-1A5B15F81FAAQ28195442-EE8A1BF6-E0C0-4131-8F58-CBE6B11E3740Q31132502-22257226-C1D9-453A-A739-2B29F7593720Q33989019-870303F8-0924-45B8-9C19-583EF62D2EF8Q34695338-9D25B4C0-5486-49EC-BDBE-2466BBC1D354Q35048860-EBF15488-4AF7-4185-9E51-718338936A1BQ35630047-9AB5AC31-305F-45A9-851B-A823361EB292Q35788500-16586E8C-B624-4656-A4F4-9DADCD30D402Q36327138-1D987847-F8BB-4860-A50F-650BC5052F4DQ36343925-5F7531A9-B209-464D-92D7-D5CDBEA6F59BQ36821548-AAF8E004-4FA1-42B9-A204-493FD3ED05BFQ37084901-6A2FDE44-0E3D-4AD9-8D00-C083D6A42746Q37119883-0757EBD2-E755-4C4B-8AA7-700A95DA94B0Q37180330-FE32B512-BB16-4915-8D2D-9914798C3E71Q37268033-A7597E68-74E9-4B9A-B3AB-F441F8B84B63Q37399268-919B16DA-9172-48EA-9C09-999D0A5CF732Q37565200-FEDC23B9-31BB-4F4A-80EE-F52E3FB1D485Q37645138-0C4C1053-4E47-45C6-A8F2-FCEC0F1111E2Q37957791-A1CEFC78-033D-4958-832D-4AA69D8085D4Q37995704-7A5CB7BE-C416-44AF-87D0-2656FEF47277Q38215678-5AD2DB09-DFF2-4254-94E3-8EB4882A4965Q38649750-E3F853F6-5749-486E-9A7A-ADBCA2870E6EQ38907149-8B21910E-2235-4318-B20A-C2F1812765B0Q39148961-2BDF113E-196E-4EEC-9229-3F3ADA5750A0Q39418010-6D463341-AF8E-4194-B7CD-979386E3C7BEQ40359398-09DD323D-741B-47BE-84A9-9098C83ECCB6Q41460345-CC15B883-97B2-4401-938D-466C1711F174Q47964767-649AF0ED-1FA5-46C9-811D-8817318078B7Q48191363-AC281E73-5DEE-438B-9468-FBF444E70A6EQ51809194-6EC0773C-A2E3-4E28-8D81-0A39A912F575Q52668077-78D3C746-EB93-46EC-AFA4-98E606122423Q54195696-88F5F050-9A36-4CAF-B198-A9EC9E3D58B6Q54475957-5CEA04CE-6F21-4BA9-88AA-A2D4D4251478Q56990903-3D8A4BC4-E162-4DF3-8A0B-45B537EA3BFCQ58696098-C1565565-3F11-463B-A825-5A72A2061027
P2860
A3 adenosine receptor activation in melanoma cells: association between receptor fate and tumor growth inhibition.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
A3 adenosine receptor activati ...... e and tumor growth inhibition.
@en
A3 adenosine receptor activati ...... e and tumor growth inhibition.
@nl
type
label
A3 adenosine receptor activati ...... e and tumor growth inhibition.
@en
A3 adenosine receptor activati ...... e and tumor growth inhibition.
@nl
prefLabel
A3 adenosine receptor activati ...... e and tumor growth inhibition.
@en
A3 adenosine receptor activati ...... e and tumor growth inhibition.
@nl
P2093
P2860
P356
P1476
A3 adenosine receptor activati ...... e and tumor growth inhibition.
@en
P2093
Avivit Ochaion
Faina Barer
Sara Bar-Yehuda
P2860
P304
42121-42130
P356
10.1074/JBC.M301243200
P407
P577
2003-07-15T00:00:00Z